PATENT CLAIM ANALYSIS

Application Number: 15763186
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "451000"]

Abstract:
The present invention relates to the use of one or more cannabinoids in the treatment of an inflammatory skin disease. Preferably the one or more cannabinoids are taken from the group consisting of: cannabidiol (CBD), cannabidiolic acid (CBDA), cannabidivarin (CBDV), cannabigerol (CBG), cannabigervarin (CBGV) and tetrahydrocannabivarin (THCV). The inflammatory skin disease may be caused by one or more of the following: microbial infection-induced dermatitis; solar dermatitis; atopic dermatitis; and allergic contact dermatitis.

Claim (Index 5):
The method according to  claim 3 , wherein the inflammatory skin disease is psoriasis.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 90.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14359192', '13634343', '14260876', '14899613', '14128208']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8120655634898707
- 35 USC 102 Novelty (BERT): 0.538358412052306
- Combined Prediction Score: 0.7846948483461141
- Mean Citation Score: 358.60656
- Max Citation Score: 386.50253
- Similarity Product: 229.0715044449001

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test